306 related articles for article (PubMed ID: 33767353)
1. A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells.
Gilad Y; Eliaz Y; Yu Y; Dean AM; Han SJ; Qin L; O'Malley BW; Lonard DM
Commun Biol; 2021 Mar; 4(1):399. PubMed ID: 33767353
[TBL] [Abstract][Full Text] [Related]
2. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
[TBL] [Abstract][Full Text] [Related]
3. AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer.
Kiliti AJ; Sharif GM; Martin MB; Wellstein A; Riegel AT
Front Endocrinol (Lausanne); 2023; 14():1250218. PubMed ID: 37711895
[TBL] [Abstract][Full Text] [Related]
4. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
Ma G; Ren Y; Wang K; He J
Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
[TBL] [Abstract][Full Text] [Related]
5. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; O'Malley BW
Mol Endocrinol; 2011 Dec; 25(12):2041-53. PubMed ID: 22053001
[TBL] [Abstract][Full Text] [Related]
6. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.
Song X; Chen J; Zhao M; Zhang C; Yu Y; Lonard DM; Chow DC; Palzkill T; Xu J; O'Malley BW; Wang J
Proc Natl Acad Sci U S A; 2016 May; 113(18):4970-5. PubMed ID: 27084884
[TBL] [Abstract][Full Text] [Related]
7. A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells.
Bozickovic O; Skartveit L; Engelsen AST; Helland T; Jonsdottir K; Flågeng MH; Fenne IS; Janssen E; Lorens JB; Bjørkhaug L; Sagen JV; Mellgren G
J Steroid Biochem Mol Biol; 2019 Jan; 185():57-70. PubMed ID: 30048685
[TBL] [Abstract][Full Text] [Related]
8. Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.
Karmakar S; Foster EA; Blackmore JK; Smith CL
Endocr Relat Cancer; 2011 Feb; 18(1):113-27. PubMed ID: 21059860
[TBL] [Abstract][Full Text] [Related]
9. Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.
Karmakar S; Gao T; Pace MC; Oesterreich S; Smith CL
Mol Endocrinol; 2010 Jun; 24(6):1187-202. PubMed ID: 20392877
[TBL] [Abstract][Full Text] [Related]
10. SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.
Li L; Deng CX; Chen Q
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946224
[TBL] [Abstract][Full Text] [Related]
11. Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy.
Lu D; Chen J; Qin L; Bijou I; Yi P; Li F; Song X; MacKenzie KR; Yu X; Yang B; Roy Chowdhury S; Korp JD; O'Malley BW; Lonard DM; Wang J
J Med Chem; 2024 Apr; 67(7):5333-5350. PubMed ID: 38551814
[TBL] [Abstract][Full Text] [Related]
12. FBXL16 modulates the proliferation and autophagy in breast cancer cells via activating SRC-3-AKT signaling pathway.
Yang M; Jing F
Reprod Biol; 2021 Sep; 21(3):100538. PubMed ID: 34333223
[TBL] [Abstract][Full Text] [Related]
13. Intrinsically Disordered SRC-3/AIB1 Protein Undergoes Homeostatic Nuclear Extrusion by Nuclear Budding While Ectopic Expression Induces Nucleophagy.
Cabrita MA; Renart LI; Lau R; Pratt MAC
Cells; 2019 Oct; 8(10):. PubMed ID: 31635050
[TBL] [Abstract][Full Text] [Related]
14. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.
Labhart P; Karmakar S; Salicru EM; Egan BS; Alexiadis V; O'Malley BW; Smith CL
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1339-44. PubMed ID: 15677324
[TBL] [Abstract][Full Text] [Related]
15. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
Lee WK; Kim WG; Fozzatti L; Park S; Zhao L; Willingham MC; Lonard D; O'Malley BW; Cheng SY
Endocr Relat Cancer; 2020 Apr; 27(4):209-220. PubMed ID: 31977311
[TBL] [Abstract][Full Text] [Related]
16. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
17. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
[TBL] [Abstract][Full Text] [Related]
18. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.
Karmakar S; Foster EA; Smith CL
Endocrinology; 2009 Apr; 150(4):1588-96. PubMed ID: 19095746
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactions.
Lake MC; Nguyen QD; Ali S; Aboagye EO
PLoS One; 2012; 7(8):e44160. PubMed ID: 22952913
[TBL] [Abstract][Full Text] [Related]
20. Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.
Rohira AD; Yan F; Wang L; Wang J; Zhou S; Lu A; Yu Y; Xu J; Lonard DM; O'Malley BW
Cancer Res; 2017 Aug; 77(16):4293-4304. PubMed ID: 28611048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
